RNA Formulation Solutions
-
Automated, Single-Use System For Clinical And Commercial LNP Production
7/21/2023
The NanoAssemblr® commercial formulation system is an automated, single-use system for the clinical and commercial production of lipid nanoparticles (LNPs) under cGMP conditions. Designed for efficient changeover and robust manufacturing processes, the system enables operational flexibility and standardized manufacturing of genomic medicines.
-
Innovative Formulations And Higher Drug Loads Across The Life-Cycle
11/20/2025
Advanced particle engineering enhances the performance and life-cycle of therapeutics. Superior bioavailability, higher drug load, and improved stability are enabled for small and large molecules.
-
Cleanrooms And Equipment For mRNA Drug Manufacturing
6/9/2023
Revolutionizing Global mRNA Production: Germfree's Innovative Cleanrooms Drive Manufacturing Success
Cleanroom requirements for mRNA manufacturing encompass stringent particle control, temperature and humidity management, solvent management and robust contamination prevention strategies. Germfree’s advanced cleanroom solutions address these challenges, ensuring seamless equipment integration, process adaptability, and compliance with regulatory standards. Their tailored mobile and modular facilities support the emerging trend for localized vaccine production, empowering biopharmaceutical companies to harness the transformative potential of mRNA technology in a rapidly advancing field, and ultimately contributing to global immunization efforts.
-
Delivering Best-In-Class Nanoparticles
6/30/2025
Achieve uniformity and control in nanoparticle synthesis with an advanced system that streamlines production, reduces human intervention, and delivers exceptional particle characteristics for diverse applications.
-
New Solutions For Large Molecule Analysis
6/16/2023
Explore Biozen LC Portfolio
With a new titanium BioTi™ biocompatible hardware to minimize priming, four particle platforms for optimal versatility and nine particle chemistries to maximize selectivity and sensitivity, Biozen UHPLC/HPLC columns are seamlessly designed to bring peace of mind to your analysis of biologics through:
- Charge Variant Analysis
- Aggregate Analysis
- Peptide Mapping
- Intact Mass Intact and Fragment Analysis
- Glycan Analysis
- Peptide Quantitation
- Drug Antibody Ratio (DAR)
- Oligonucleotide Characterization
-
Non-Viral Gene Delivery (NVGD) Using Polymeric-Nano Particles
Examine a NVGD platform that tackles the primary obstacle hindering gene editing therapies: efficient delivery. Utilizing engineered nanoparticles, the platform overcomes limitations associated with payload size.
-
NanoImprove The Performance Of Your Biologic Formulation
11/20/2025
Unlock superior performance for peptides and proteins using nanotechnology. Achieve high drug loads for subcutaneous delivery and stable, aerodynamic dry powders for deep-lung inhalation.
-
Accelerating Gene Therapy With The HIT SCAN Platform
4/7/2025
Battelle’s HIT SCAN™ platform accelerates gene therapy by using high-throughput methods to design, screen, and optimize polymer nanoparticles (PNPs) for effective, non-viral delivery.
-
Metabolite And Lipid Analysis Service
10/29/2024
Unlock actionable insights into your cell culture process with metabolite and lipid analysis, enabling data-driven optimizations for growth, titer, and product quality.
-
Systems For Lipid Nanoparticle (LNP) Production
12/6/2024
Delve into the world of lipid nanoparticle (LNP) production and formulation, exploring cutting-edge technologies and applications in targeted drug delivery.